These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35224957)

  • 41. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.
    Pasero D; Sanna S; Liperi C; Piredda D; Branca GP; Casadio L; Simeo R; Buselli A; Rizzo D; Bussu F; Rubino S; Terragni P
    Infection; 2021 Oct; 49(5):1055-1060. PubMed ID: 33331988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report.
    de Ruijter NS; Kramer G; Gons RAR; Hengstman GJD
    Mult Scler Relat Disord; 2020 Nov; 46():102474. PubMed ID: 32892062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucormycosis, conflicts and COVID-19: A deadly recipe for the fragile health system of Afghanistan.
    Essar MY; Khan H; Babar MS; Hasan MM; Rackimuthu S; Dos Santos Costa AC; Ahmad S; Nemat A
    Int J Health Plann Manage; 2022 Jan; 37(1):543-546. PubMed ID: 34333804
    [No Abstract]   [Full Text] [Related]  

  • 45. Cutaneous mucormycosis: an unusual cause of decompensation in a patient with ethanol-related cirrhosis with COVID-19 exposure.
    Menezes S; Kumar JS; Rudra OS; Nagral A
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35140094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 infection among patients with systemic autoimmune diseases.
    Emmi G; Bettiol A; Mattioli I; Silvestri E; Di Scala G; Urban ML; Vaglio A; Prisco D
    Autoimmun Rev; 2020 Jul; 19(7):102575. PubMed ID: 32376395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anesthetic outcomes in pediatric patients with COVID-19: A matched cohort study.
    Cronin JA; Nelson JH; Farquhar I; Braffett B; Bebu I; Pestieau SR; Geng-Ramos G; Heitmiller E; Deutsch N
    Paediatr Anaesth; 2021 Jun; 31(6):733-735. PubMed ID: 33713490
    [No Abstract]   [Full Text] [Related]  

  • 48. Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit.
    Mulakavalupil B; Vaity C; Joshi S; Misra A; Pandit RA
    Diabetes Metab Syndr; 2021; 15(4):102169. PubMed ID: 34198110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis.
    Arora N; Gudipati A; Kundu R; Prabhakar N; Suri V; Malhotra P; Jain A
    Lancet Infect Dis; 2021 Nov; 21(11):1611. PubMed ID: 34717815
    [No Abstract]   [Full Text] [Related]  

  • 50. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?
    Lugito NPH; Cucunawangsih C
    Mycopathologia; 2021 Dec; 186(6):877-882. PubMed ID: 34623597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
    Kaur K; Gurnani B
    Indian J Pharmacol; 2021; 53(5):417-419. PubMed ID: 34854414
    [No Abstract]   [Full Text] [Related]  

  • 53. Covid-19 associated Mucormycosis: A case report.
    Shrestha O; Sharma Baral R
    J Nepal Health Res Counc; 2021 Sep; 19(2):414-416. PubMed ID: 34601541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Considerations on SARS-Cov-2 vaccines in patients with autoimmune blistering diseases.
    Cozzani E; Gasparini G; Sticchi L; Russo R; Icardi G; Parodi A
    Eur J Dermatol; 2021 Jun; 31(3):415-417. PubMed ID: 34309530
    [No Abstract]   [Full Text] [Related]  

  • 55. Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy.
    Benfaremo D; Perini L; Marconi V; Luchetti MM; Gabrielli A
    Eur J Intern Med; 2021 Jan; 83():90-92. PubMed ID: 33092952
    [No Abstract]   [Full Text] [Related]  

  • 56. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?
    Revannavar SM; P S S; Samaga L; V K V
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33906877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum.
    Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK
    Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.
    Garg D; Muthu V; Sehgal IS; Ramachandran R; Kaur H; Bhalla A; Puri GD; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 May; 186(2):289-298. PubMed ID: 33544266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.
    Kharlamova N; Dunn N; Bedri SK; Jerling S; Almgren M; Faustini F; Gunnarsson I; Rönnelid J; Pullerits R; Gjertsson I; Lundberg K; Månberg A; Pin E; Nilsson P; Hober S; Fink K; Fogdell-Hahn A
    Front Immunol; 2021; 12():666114. PubMed ID: 34012450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mucormycosis Epidemic and Stroke in India During the COVID-19 Pandemic.
    Padma Srivastava MV; Vishnu VY; Pandit AK
    Stroke; 2021 Oct; 52(10):e622-e623. PubMed ID: 34525840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.